PPT-61 y/o man CKD on hemodialysis for 11
Author : natalie | Published Date : 2022-06-01
yr amp gout received cacarbonatecalcitriolEPO allopurinol Stress FX bone deformity osteoporesis Pancytopnea spleenomegally High ca alk ph pth Parathyroid adenoma
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "61 y/o man CKD on hemodialysis for 11" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
61 y/o man CKD on hemodialysis for 11: Transcript
yr amp gout received cacarbonatecalcitriolEPO allopurinol Stress FX bone deformity osteoporesis Pancytopnea spleenomegally High ca alk ph pth Parathyroid adenoma in MIBI. Josh Exley. Learning Objectives. Acute Kidney Injury. Drugs and the Kidney. Chronic Kidney Disease. Normal Kidney function. Kidney Functions. Excretory function. Filter metabolites, toxins, drugs. Homeostatic function. Metformin must be considered the cornerstone of treatment when not contraindicated (eGFR <30). In patients not at goal on metformin monotherapy, adding an SGLT. 2. inhibitor like empagliflozin is warranted when not contraindicated (eGFR <45). ( ) CVD benefit ?Class effect?. Program Goals. Hepcidin in Chronic Kidney Disease. Treatment of Iron Deficiency Anemia. Assessment of IV Iron in Patients With Non-Dialysis-Dependent CKD. DOPPS Study. Ferric Pyrophosphate. Phosphate Binders. 2017 . Annual Data Report. Volume 1: Chronic Kidney Disease. 2. vol 1 Figure 7.1 Sources of prescription drug coverage in Medicare enrollees, by population, 201. 5. Data source: Medicare 5% sample. Point prevalent Medicare enrollees alive on January 1, 2015. Abbreviations: CKD, chronic kidney disease; LIS, Medicare Low-income Subsidy; Part D, Medicare prescription drug coverage benefit.. scenario in Nepal. Presentation By. :. Ms. Niru Khatiwada. BSc Nursing (BPKIHS), MN (IOM, TU). Lecturer, Nepal Medical College . (Affiliated to Kathmandu University). Kathmandu, Nepal. 1. OVERVIEW. OVERVIEW. Learning Objectives. Facilitate timely testing and intervention in patients at-risk for chronic kidney disease (CKD).. Apply appropriate . clinical measures . to manage risk and increase . patient . safety in CKD.. GUIDELINES FROM. 5 MEDICAL SOCIETIES IN . NORTH AMERICA, EUROPE AND ASIA. Increased Time and Frequency. OVERVIEW. Proliferation of research about intensive hemodialysis has led to better understanding of when to increase hemodialysis time and frequency. Case 201-cv-00779-WBS -CKD Document 142 Filed 04/29/05 Page 2 of 2123456789-1- RD 1234567892 R Lowell Dilworth-Chemical Pathologist. CKD. CKD and Bone disease. Mineral . metabolism controlled by kidneys. , intestine, parathyroid glands and . bone. The . kidney plays a critical role in mineral homeostasis regulation and, therefore, renal disease exerts widespread effects on the skeleton and soft . Definition of CKD. Staging of CKD. Etiology of CKD. How to measure Kidney function . Incidence of ESRD. (per million population, 1990, by HSA, unadjusted). USRDS, 2000. Incidence of ESRD. (per million population, 2000, by HSA, unadjusted) . KDIGO Guideline Co-Chairs:. Alfred K. Cheung, MD. Johannes F.E. Mann, MD. Guideline: . Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1–S87. Figure . 4.1 . Vascular access use at hemodialysis initiation, . from . the ESRD Medical Evidence form (CMS 2728), 2005-2013. Vol 2, ESRD, . Ch. 4. 2. 3. AV. fistula. AV graft. Catheter with maturing fistula. . Structural . or functional abnormalities of the kidneys for . >. 3 months. . from early to late-stage disease, . Chronic Kidney Disease. as . manifested by either:. 1. Kidney . damage, with or without decreased GFR, as . Assistant Professor of Clinical Medicine . In-Center Medical Director/Co-Medical Director @ Stony Brook Kidney Center. Division of Nephrology & Hypertension . Stony Brook Medicine . Break down of Hemodialysis lectures.
Download Document
Here is the link to download the presentation.
"61 y/o man CKD on hemodialysis for 11"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents